Titan PharmaceuticalsTTNP
13F holders, Q3 2024 (September 30)16holders −2
1new positions
3sold out
1famous investor
$5.27avg. 13F price*
At the end of Q3 2024, 16 institutions reported holding Titan Pharmaceuticals Inc. (TTNP) in their 13F filings, down 2 from Q2 2024. 1 opened new positions and 3 sold out. The largest holders were Renaissance Technologies ($58K), UBS Group AG ($25K) and Tower Research Capital LLC (TRC) ($4K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Titan Pharmaceuticals Inc.
- CUSIP
- 888314705
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $58K |
| Exits | 3 | $174K |
All 13F filers, Q2 2024 → Q3 2024: 15,865 shares bought and 31,257 shares sold, net −15,392 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Renaissance Technologies | 0.00% | New | 11,066 | $58K |
| UBS Group AG | 0.00% | Add +477200.0% | 4,773 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +3.6% | 743 | $4K |
| MCF Advisors LLC | 0.00% | No change | 165 | $870 |
| Bank of America Corp. | 0.00% | No change | 17 | $89 |
| Group One Trading LLC | 0.00% | No change | 12 | $64 |
| Osaic Holdings, Inc. | 0.00% | No change | 10 | $52 |
| Morgan Stanley | 0.00% | Add +33.3% | 4 | $21 |
| Global Wealth Strategies & Associates | 0.00% | No change | 2 | $11 |
| Nemes Rush Group LLC | 0.00% | No change | 1 | $7 |
| Wells Fargo & Company | 0.00% | No change | 1 | $5 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 1 | $5 |
| St Germain D J Co. Inc. | 0.00% | No change | 1 | $5 |
| Westside Investment Management, Inc. | 0.00% | No change | 1 | $5 |
| Cape Investment Advisory, Inc. | 0.00% | No change | 1 | $5 |
| Ransom Advisory, Ltd | 0.00% | No change | 1 | $5 |
"% of holder's portfolio" is TTNP's weight in each manager's 13F, not the share of Titan Pharmaceuticals Inc. the manager owns.